Ann: New Data at SITC Meeting. Further Studies Announced, page-60

Lopez... I did post a reply to you, but don't know why it came out as shown above.
Given the vagueness and total lack of detail, I do not feel I am breaching ethics if I copy and paste it now.

"Thanks for the note and your continued support of the company. I appreciate your frustration and that of other shareholders regarding lack of reporting specifically on ‘interest’ from bigger players. To your request for information ‘in the broadest terms’ we have reported on prominent exposure at major conferences and publically indicated being on the radar of big pharma groups.  

I am not able to provide you anything not otherwise disclosed to the market for reasons which I am sure you understand.  Again, your longstanding support is appreciated and please keep an eye out for future news flow, including data being presented at the SITC Conference starting on 8th November".

Read into that what you will.